UIPath has rebounded approximately 75% from recent lows but remains far below its 2021 IPO peak. PATH is a software company focused on robotic process automation. There is spirited debate as to its positioning amid the current AI transformation. The company has delivered consistent but fairly modest growth in recent years.
UiPath has successfully integrated generative AI into its RPA platform, reigniting growth and customer traction. PATH achieved 11% YoY ARR growth and positive GAAP operating income, with management now committed to sustained GAAP profitability. PATH trades at less than 6x forward sales which looks compelling given the profitability outlook.
UiPath: Further Upward Re-Rating Is Overdue
UiPath Inc. ( PATH ) Barclays 23rd Annual Global Technology Conference December 10, 2025 2:00 PM EST Company Participants Ashim Gupta - CFO & COO Conference Call Participants Raimo Lenschow - Barclays Bank PLC, Research Division Presentation Raimo Lenschow Barclays Bank PLC, Research Division So let's start -- like to get everyone on the same page, just Ashim, you had like really healthy Q3 results last week. Shares were up a lot.
UiPath (PATH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
UiPath (PATH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
UiPath's expanding alliances with Microsoft, Amazon and Salesforce boost its global automation reach and help it outperform its industry.
UiPath stock surged as it looks to be brushing off previous concerns about cuts to government spending and AI competition.
UiPath Inc. (PATH) Q3 2026 Earnings Call Transcript
The headline numbers for UiPath (PATH) give insight into how the company performed in the quarter ended October 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
UiPath (PATH) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.11 per share a year ago.
Evaluate the expected performance of UiPath (PATH) for the quarter ended October 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.